In the current study, we provided a comprehensive overall expression profile of CD44 in ovarian cancer, from individual patients’ clinical primary tumor tissue to metastasis and recurrence, and from tumor cell lines to xenograft mouse model. The gene discussed is CD44; the disease is ovarian carcinoma.